If you have an unexpired EMERADE® auto-injector return it to your pharmacy
Voluntary recall by Bausch Health, Canada with Health Canada
If you have unexpired EMERADE® epinephrine auto-injectors, return them to your pharmacy as soon as possible.
There are other epinephrine auto-injectors available through pharmacies across Canada.
EMERADE® Sterile Epinephrine Injection is indicated for the emergency treatment of severe allergic reactions (anaphylaxis) triggered by allergens in foods, medicines, insect stings or bites, and other allergens and for exercise-induced or idiopathic anaphylaxis.
Bausch Health, Canada chose to initiate this voluntary action due to the potential risk that the auto-injector may fail to activate or activate prematurely if dropped. The decision to conduct this voluntary recall is part of our ongoing commitment to ensuring all our products meet the highest standards of quality. We take matters such as this very seriously, which is why we are taking this recall action.
The company has informed Health Canada about this action and is implementing their recommended recall protocols.
Communications have been issued to wholesalers and pharmacists across Canada to immediately stop all sales of EMERADE® and information about this recall has also been communicated to doctors.
If you have questions about this voluntary recall or would like additional information, please contact Bausch Health, Canada Inc. Customer Service at 1-800-361-4261.
We’re excited and proud to bring you an epinephrine option for your severe allergic reactions. We’re committed to support you.
Whether it’s your loved ones, friends or your healthcare provider, help is nearby. If you have any questions regarding severe allergic reactions, your treatment or your EMERADE®, you can always reach out to us.
With over 15 years of experience and through collaboration with allergy specialists and patients, the EMERADE® team was able to develop this epinephrine auto-injector.
Developed by Medeca Pharma AB, a pharmaceutical company specialized in allergy and anaphylaxis since 1991.